The Debugger
for the Brain
Runtime Observability for the Functional Connectome.
Psychiatry infers internal states from external behavior. Satori Bio instruments the brain directly by treating it as a dynamic system. We apply physics-constrained models to turn raw electrical signals into a runtime telemetry, creating the first true debugger for clinical neuroscience.
Investor & Partnership Inquiries contact@satoribio.ai
Why Now?
Tools to objectively measure brain function at scale still don’t exist. New neural telemetry and physics-constrained modeling make direct observation possible. Satori Bio advances these capabilities, generating structured biomarkers and predictive insight into brain dynamics.
A Platform for Neural Insight.
Satori Bio unifies physics-informed modeling, high-resolution neural measurement, and advanced machine intelligence to map brain activity into structured, predictive representations tied to individual treatment response. In contrast to retrospective analytics and subjective assessments, our platform extracts meaningful neural dynamics that enhance both clinical and translational research insight.
Team
Building Psychiatry’s First Brain Observability Platform
Bryan Hall — Cofounder & CEO
Two-time founder with one prior exit. Former Head of Data & AI at Seismic, as they scaled from $100M to $3B. Brings 30 years of experience extracting signal from noisy, high-stakes data. Founder-market fit shaped by lived experience as a caretaker navigating repeated psychiatric treatment failure.
Brian Horsley — Cofounder & CTO
Veteran hardware and software architect with 30+ years of experience building and deploying large-scale, production systems. Led development of IoT and edge platforms deployed across 18,000+ units, including national rollouts for Barnes & Noble and Blockbuster.
Jacopo Annese — Chief Scientific Officer
Neuroscientist and pioneer in human brain structure–function mapping. Led landmark post-mortem imaging work on Patient H.M., one of the most influential cases in neuroscience. Deep expertise in linking brain anatomy, dynamics, and cognition.
Helena Voetterl — Scientific Advisor
Developer of the first clinically viable EEG biomarker for treatment-resistant depression. Author of 20+ peer-reviewed publications in MDD and neural biomarkers, with extensive experience translating research biomarkers into real-world clinical studies.
This team combines deep neuroscience, large-scale systems engineering, and real-world clinical grounding to tackle psychiatry’s core observability gap.